Evidence map›Paper›PMID 41214614›Full record

ArticleBMC medicine2025

Evaluating a novel multi-species vector control tool for humanitarian crises: the efficacy of attractive targeted sugar baits among forcibly displaced populations in Northern Nigeria.

Richard James Allan, Mohammad Kamal, Sajjad Ahmad, Muhammad Musa Ibrahim, Umar Ba'abba Goni, Garba Mohammed Ashir, Mala Waziri, Blaise Nfornuh Alenwi, Sara Estecha-Querol, Karen Lorena Figueroa Chilito and 3 more

Abstract read
In one paragraph

Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Richard James AllanThe MENTOR Initiative, Haywards Heath, UK. richard.allan@mentor-initiative.org.
Mohammad KamalThe MENTOR Initiative, Maiduguri, Nigeria.
Sajjad AhmadThe MENTOR Initiative, Maiduguri, Nigeria.
Muhammad Musa IbrahimThe MENTOR Initiative, Maiduguri, Nigeria.
Umar Ba'abba GoniThe MENTOR Initiative, Maiduguri, Nigeria.
Garba Mohammed AshirThe University of Maiduguri, Maiduguri, Nigeria.
Mala WaziriState Malaria Elimination Program, Ministry of Health, Maiduguri, Borno State, Nigeria.
Blaise Nfornuh AlenwiThe MENTOR Initiative, Maiduguri, Nigeria.
Sara Estecha-QuerolThe MENTOR Initiative, Haywards Heath, UK.
Karen Lorena Figueroa ChilitoSchool of Public Health, University of Nevada, Las Vegas, NV, USA.
David WeetmanLiverpool School of Tropical Medicine, Liverpool, UK.
Godwin NtadomNational Malaria Elimination Programme, Ministry of Health, Abuja, Nigeria.
Louisa Alexandra MessengerSchool of Public Health, University of Nevada, Las Vegas, NV, USA.

Funding

Department of the Army, U.S. Army Contracting Command, Aberdeen Proving Ground, Edgewood Contracting Division, Ft Detrick MD W911QY-22-1-0002
6 · The paper itself

Abstract

backgroundArmed conflicts, natural disasters and forced population displacement have escalated dramatically since the 1990s. By mid-2024, the total number of people driven from their homes, often surviving in very harsh conditions for years, reached 122.6 million globally. In emergencies characterised by flimsy shelters, food insecurity, inadequate sanitation, poor access to health services and increased exposure to blood-feeding insects, diseases such as malaria, dengue and leishmaniasis cause high levels of morbidity and mortality. Conventional vector control interventions are inadequate in these settings due to operational and biological limitations. Novel vector control tools which are lightweight, easy to use and effective against multiple vector species are urgently needed to protect displaced populations.

methodsWe conducted a 6-month, 2-arm community field trial in two internally displaced people camps in Maiduguri, Nigeria, to evaluate the entomological efficacy of attractive targeted sugar baits (ATSB). Monthly entomological monitoring measured changes in adult and immature vector density. Intervention acceptability was assessed using focus group discussions and a cross-sectional survey. To investigate environmental drivers of vector abundance, which might influence field outcomes, a hybrid approach of unsupervised and supervised machine learning regression models was developed using composite demographic, bioclimatic and ecological remote sensing data.

resultsATSB demonstrated a significant impact on indoor female Anopheles gambiae s.l. density (IRR: 0.140 [95% CI: 0.093-0.212]; p < 0.0001) and indoor blood-fed An. gambiae s.l. density (IRR: 0.0193 [95% credible interval: 0.0111-0.0356]). ATSB also significantly reduced indoor blood-fed Aedes aegypti (IRR: 0.0746 [95% credible intervals: 0.00884-0.502]). More than 97% of camp residents showed high levels of acceptance for ATSB, including willingness to pay. The strongest environmental predictors of An. gambiae s.l. occurrence were composite indices of vegetation water content, soil moisture, moist canopy, landcover diversity, urbanisation and normalised and enhanced vegetation index which together contributed to 73.5% of the final model.

conclusionsField trial findings strongly support the use of ATSB to control sympatric malaria and dengue vector populations in humanitarian crises. Remote sensing analysis identified key drivers of An. gambiae s.l. occurrence providing a high-resolution environmental profile where ATSB achieved an entomological impact against multiple vector species.

Indexed as

AnophelesMosquito ControlMosquito VectorsRefugeesSugarsAdultAltruismAnimalsCross-Sectional StudiesFemaleHumansMaleNigeriaSugarsAttractive targeted sugar baitsConflictDengueInternally displaced personsMalariaTemporary shelterVector control

Identifiers

PMID41214614
PMCPMC12604231

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.